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Summary. Histochemical marker genes were used to 
"tag" mouse fibrosarcoma or human neuroblastoma 
cells,  providing a better understanding of their 
subsequent progression and metastasis mechanisms in 
nude mice. Micrometastases in the lung were initiated 
from clusters of 2-6 cells rather than single cells in most 
cases; tumor cells were also visualized binding to the 
endothelium of small blood vessels to initiate these 
micrometastases. Shortterm, these mechanisms relied 
heavily on fluidity of cell surface proteins, rather than 
nuclear events. Micrometastases in some organs were 
transient and never became established. Angiogenesis 
was visualized in both primary tumor systems via 
"fixation" of the animal's circulation; very small micro- 
vessels were growing toward the primary tumor as soon 
as 48-72 hours post-injection. Marker genes were also 
valuable for quantitating genetic instability of specific 
tumor cell populations and potential gene regulatory 
mechanisms operating in specific organ sites. These 
latter studies have direct relevance to the significance of 
N-myc oncogene amplification in neuroblastoma during 
progression and CD44 gene plasticity of expression in 
fibrosarcoma during metastasis. Marker gene-tagged 
single tumor cells can now be analyzed for gene 
regulatory events in virtually any organ and in 
combination with laser capture microdissection and 
other high-resolution methodologies, providing insight 
into the very earliest gene-regulatory events during 
micrometastasis. 
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Introduction and background 
Primary tumors develop from the original 
malignantly-converted cell via activation of oncogene(s) 
and downregulation of specific tumor-suppressor 
gene(s). Progression of the primary tumor from a small 
collection of tumor cells into a large, palpable tumor, 
along with the generation of small subpopulations of 
these tumor cells competent to undergo metastatic spread 
to various target organs, presumably involve many other 
genes. The products of these genes are responsible for 
specific cellular physiological events associated with 
progression and metastasis. These multiple events are 
complex and difficult to analyze, even in experimental 
animal model systems. 
In the mid-1970s, investigators began to analyze 
these progression and metastasis mechanisms using 
human and mouse melanoma cells that could be easily 
identified and quantitated in target organs based on their 
black pigment via expression of melanin genes (Fidler et 
al., 1978). In non-melanoma tumor systems, this ease of 
identification was impossible, although quantitation 
could be effected by transfection of a drug-resistance 
gene into the tumor population and enumerating drug- 
resistant colonies grown out in culture (Heppner and 
Miller, 1983; Miller et al., 1987). The frustration of 
"trackingy7 fibrosarcoma or neuroblastoma tumor cells 
during metastasis in our own studies (Radinsky et al., 
1987; Culp and Barletta, 1990), combined with the novel 
use of histochemical marker genes transfected into 
embryo cells to track cell lineages (Sanes et al., 1986), 
induced us to try a similar approach in analyzing tumor 
progression/metastasis (Lin et al., 1990a,b). This has 
been a highly rewarding endeavor, allowing us in both 
fibrosarcoma and neuroblastoma tumor systems to 
analyze the earliest events in micrometastasis and 
progression at the single-cell level. Some of these 
studies will be reviewed here. 
One novel finding involved characterization of 







